We are live on ! Find out more
LAB icon

Standard BioTools
LAB

83 hedge funds and large institutions have $196M invested in Standard BioTools in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

92.38% more ownership

Funds ownership: 0% → 92.38% (+92%)

7% more capital invested

Capital invested by funds: $182M → $196M (+$13.3M)

4% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 27

15% less funds holding

Funds holding: 98 → 83 (-15)

43% less call options, than puts

Call options by funds: $74K | Put options by funds: $130K

56% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 25

Holders
83
Holders Change
-15
Holders Change %
-15.31%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
26
Reduced
27
Closed
25
Calls
$74K
Puts
$130K
Net Calls
-$56K
Net Calls Change
+$167K

Top Buyers

1
LCS
Levin Capital Strategies
New York
+$8.61M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.75M
3
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$1.08M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$1M
5
Citadel Advisors
Citadel Advisors
Florida
+$709K

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$15.9M
2
Millennium Management
Millennium Management
New York
-$2.38M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$2.31M
4
Lazard Asset Management
Lazard Asset Management
New York
-$2.26M
5
EAM
EverPoint Asset Management
Connecticut
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$906K -$65.5K -10,425 -8%
Deutsche Bank
27
Deutsche Bank
Germany
$867K +$258K +41,080 +52%
BIM
28
BlackRock Investment Management
Delaware
$850K -$4.68K -746 -0.6%
Charles Schwab
29
Charles Schwab
California
$728K +$32.9K +5,236 +6%
WMSA
30
Weiss Multi-Strategy Advisers
New York
$728K +$440K +70,000 +233%
Morgan Stanley
31
Morgan Stanley
New York
$624K +$499K +79,473 +1,259%
TCIM
32
TIAA CREF Investment Management
New York
$607K -$138K -22,053 -21%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$436K -$9.42K -1,500 -2%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$414K – – –
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$410K +$64.7K +10,300 +22%
TA
36
Teachers Advisors
New York
$326K -$33.9K -5,399 -11%
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$317K +$273K +43,505 New
Ohio Public Employees Retirement System (OPERS)
38
Ohio Public Employees Retirement System (OPERS)
Ohio
$311K -$120K -19,045 -29%
PP
39
PDT Partners
New York
$304K +$72.2K +11,500 +38%
AllianceBernstein
40
AllianceBernstein
Tennessee
$298K -$3.96K -630 -2%
FPC
41
Falcon Point Capital
California
$287K +$8.58K +1,366 +4%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$280K – – –
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$225K -$16.1K -2,557 -8%
PP
44
Paloma Partners
Connecticut
$217K +$187K +29,807 New
State Board of Administration of Florida Retirement System
45
State Board of Administration of Florida Retirement System
Florida
$200K – – –
SIP
46
Stoneridge Investment Partners
Pennsylvania
$177K – – –
Wells Fargo
47
Wells Fargo
California
$162K +$62.1K +9,894 +80%
Connor, Clark & Lunn Investment Management (CC&L)
48
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$161K -$225K -35,775 -62%
Millennium Management
49
Millennium Management
New York
$160K -$2.38M -379,357 -95%
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$153K -$5.38K -857 -4%
1
2
3 4 5

LAB Hedge Fund Activity: Q4 2016 in Review

83 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2016, worth a combined $196M — up 7.3% from $182M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of LAB and 11 opened new positions — a net loss of 14 holders — while 27 trimmed existing stakes and 26 added.

The largest buyer was Levin Capital Strategies, adding an estimated $8.61M. The largest seller was Franklin Resources, exiting entirely with an estimated $15.9M sold.

  • 83 institutional investors held Standard BioTools (LAB) as of Q4 2016, down from 98 in Q3 2016.
  • Funds reported $196M of Standard BioTools stock for Q4 2016, up 7.3% quarter-over-quarter.
  • 11 funds opened new Standard BioTools positions in Q4 2016 and 25 closed out, a net change of -14 holders.
  • The largest Standard BioTools buyer in Q4 2016 was Levin Capital Strategies, an estimated $8.61M added.
  • The largest Standard BioTools seller in Q4 2016 was Franklin Resources, an estimated $15.9M sold.

Based on aggregated 13F filings for Q4 2016.